1 Min Read
Feb 28 (Reuters) - XBRANE BIOPHARMA AB:
* Q4 EBITDA LOSS SEK 18.0 MILLION VERSUS LOSS SEK 8.1 MILLION YEAR AGO
* PROPOSE NO DIVIDEND FOR FISCAL YEAR 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.